Novavax CEO: COVID-19 vaccine manufacturing hurdles won’t go away anytime soon

Novavax (NVAX) is poised to be one of the next vaccines to receive emergency use authorization (EUA) in the U.S.
CEO Stanley Erck has been busy expanding manufacturing capacity for several countries… [read more]

Leave a Comment